Zota Health Care Ltd

NSE
ZOTA •
BUY

1W Return

-%

1M Return

-%

6M Return

-%

1Y Return

-%

3Y Return

-%

Start SIP in Zota Health Care Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
84.63% Gain from 52W Low
23.5
TTM PE Ratio
Negative PE TTM
-128
Price to Book Ratio
High in industry
16
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is less than 1
0.9
RSI
RSI is mid-range
58.4
MFI
MFI is mid-range
47.7

Zota Health Care Ltd Key Financials

*All values are in ₹ Cr.

Zota Health Care Ltd shareholding Pattern

Promoter
66.2%
Public
33%

Zota Health Care Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
488.10
10Day EMA
485.50
12Day EMA
485.40
20Day EMA
485.40
26Day EMA
484.90
50Day EMA
478.80
100Day EMA
459.30
200Day EMA
423.10
Delivery & Volume
Resistance & Support
501.83
Pivot
Resistance
First Resistance
511.67
Second Resistance
524.83
Third Resistance
534.67
Support
First Support
488.67
Second support
478.83
Third Support
465.67
Relative Strength Index
58.38
Money Flow Index
47.72
MACD
0.54
MACD Signal
0.20
Average True Range
17.61
Average Directional Index
23.05
Rate of Change (21)
3.77
Rate of Change (125)
9.51

Zota Health Care Ltd Company background

Founded in: 2000
Managing director: Moxesh Zota
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and overthecounter (OTC) products. The Company was incorporated in July 12, 2000 and is based out of Surat, Gujarat. The Company meets the requirements of millions of people by increasing access to highquality, affordable medicines for chronic illnesses including heart disease, diabetes, thyroid disease, and others, giving Indias pharmaceutical industry a boost.The Company has three business verticals: Marketinga traditional business vertical, and driving business verticals Exports and Retail harmacy Chain. Through its chain, Davaindia, the largest privatesector generic pharmacy chain, the Company is making strong inroads into the generic retail pharmacy business. The Companys stateoftheart manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts, i.e. 30% to 90%, to their branded equivalents. Davaindia focuses on privatelabel products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments.The Marketing business vertical involves the direct distribution of generic drugs, OTC products, and other pharmaceutical products through the Companys distribution network across India. In domestic Marketing business, the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories, such as generics, OTC products, allopathic, ayurvedic, etcetera, the Company cater to a variety of ailments. Currently, the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales, distribution, and promotion activities, its distributors engage in ethical marketing or other sales, distribution, and promotion activities on their own. Instead, it provide distributors directly with incentives to help them sell products more effectively.Secondly, the exports business vertical started in 2010, following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present, it has product approvals in 30 countries, particularly in the semiregulated and regulated markets in the African, Asian, CIS, and Latin American countries. In this facility, the Company make around 250 formulations for direct exports and contract manufacturing. . At present, the Company has 253 dossiers approved across multiple countries, and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration, the results of which are now apparent in the form of product approvals and expansion of export operations. In the Retail Pharmacy Chain business vertical, the Company operates a chain of pharmacy stores under the brand Davaindia. Davaindia focuses only on privatelabel products in the medicinal, OTC, and ayurvedic categories, with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest privatesector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique assetlight franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products, with more than 95% of products being privatelabel. In all areas and media, such as TV commercials, printing, digital social media, radio, among others, the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating topofthemind brand recall for Davaindia. Davaindia being a frontrunner in private sector generic pharmacy has also assumed the responsibility to create awareness, propagate virtues and debunk misconceptions about generic drugs. Marketing efforts are receiving very encouraging results from prospective franchisees and potential customers. The Company witnessed a substantial improvement in average wallet spend, footfall at stores, and the number of inquiries for new franchisees with aggressive marketing campaigns. The Company has started a series of promotions, including TV and digital advertisements featuring Mr Kapil Dev. Mr Kapil Dev, as an icon,stands for integrity, excellence and willpower, the Company strongly feels he is the perfect fit for endorsing the culture and spirit of Davaindia and Zota Health Care Limited.
Read More

Zota Health Care Ltd FAQs

The past 1-year return of Zota Health Care Ltd [ZOTA] share was 60.26. The Zota Health Care Ltd [ZOTA] share hit a 1-year low of Rs. 270 and a 1-year high of Rs. 532.9.

The market cap of Zota Health Care Ltd is Rs. 1288.49 Cr. as of 2/20/2024 12:00:00 AM.

The PE ratios of Zota Health Care Ltd is 386.43 as of 2/20/2024 12:00:00 AM.

The PB ratios of Zota Health Care Ltd is 10.5 as of 2/20/2024 12:00:00 AM

You can easily buy Zota Health Care Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage